fsp1 is a glutathione FSP1, key ferroptosis suppressor with therapeutic potential The CoQ oxidoreductase FSP1 acts

Use immediately after preparation Duration of therapy: Varies by condition (weeks to several months) Contraindications Known hypersensitivity to glutathione or any formulation component Use in pregnancy or breastfeeding without medical supervision History of severe allergic reactions to similar substances Precautions and Warnings Caution in renal impairment due to risk of accumulation Monitor liver function tests regularly Do not use as monotherapy in severe disease states Asthmatic patients may be at risk of bronchospasm Off-label use (e.g., skin whitening) requires medical oversight Adverse Effects Local reactions: Pain, swelling, redness at injection site Allergic reactions: Rash, itching, rarely anaphylaxis Respiratory: Mild bronchospasm (rare) Neurological: Headache or dizziness (rare) Drug Interactions May potentiate effects of certain chemotherapeutic agents consult oncology specialist No significant interactions known, but always disclose all medications to the healthcare provider Pregnancy and Lactation Use only under medical advice if pregnant or breastfeeding

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

Muscle preservation during fat loss One of the most significant concerns with any fat loss protocol is muscle loss

Int J Mol Sci 24(10):8465

Masadeh MM, Alzoubi KH, Masadeh MM, Aburashed ZO

Bcl-2 is posited as an anti-apoptotic protein that apparently inhibits cell death, while Bax is suggested to be a pro-apoptotic protein that promotes cell death